These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 16525567)
1. Genetic influences on fibrinogen, tissue plasminogen activator-antigen and von Willebrand factor in males and females. de Lange M; de Geus EJ; Kluft C; Meijer P; van Doornen LJ; Boomsma DI; Snieder H Thromb Haemost; 2006 Mar; 95(3):414-9. PubMed ID: 16525567 [TBL] [Abstract][Full Text] [Related]
2. The genetics of haemostasis: a twin study. de Lange M; Snieder H; Ariëns RA; Spector TD; Grant PJ Lancet; 2001 Jan; 357(9250):101-5. PubMed ID: 11197396 [TBL] [Abstract][Full Text] [Related]
3. Endothelial haemostatic factors are associated with progression of urinary albumin excretion in clinically healthy subjects: a 4-year prospective study. Clausen P; Feldt-Rasmussen B; Jensen G; Jensen JS Clin Sci (Lond); 1999 Jul; 97(1):37-43. PubMed ID: 10369792 [TBL] [Abstract][Full Text] [Related]
4. Haemostatic factors and the risk of cardiovascular death in patients with coronary artery disease: the AtheroGene study. Morange PE; Bickel C; Nicaud V; Schnabel R; Rupprecht HJ; Peetz D; Lackner KJ; Cambien F; Blankenberg S; Tiret L; Arterioscler Thromb Vasc Biol; 2006 Dec; 26(12):2793-9. PubMed ID: 17023678 [TBL] [Abstract][Full Text] [Related]
5. Associations of von Willebrand factor, fibrin D-dimer and tissue plasminogen activator with incident coronary heart disease: British Women's Heart and Health cohort study. May M; Lawlor DA; Patel R; Rumley A; Lowe G; Ebrahim S Eur J Cardiovasc Prev Rehabil; 2007 Oct; 14(5):638-45. PubMed ID: 17925622 [TBL] [Abstract][Full Text] [Related]
7. Sex differences in coagulation and fibrinolysis in subjects with coronary artery disease. Ossei-Gerning N; Wilson IJ; Grant PJ Thromb Haemost; 1998 Apr; 79(4):736-40. PubMed ID: 9569183 [TBL] [Abstract][Full Text] [Related]
8. Plasma fibrinogen, haemostatic factors and prediction of peripheral arterial disease in the Edinburgh Artery Study. Smith FB; Lee AJ; Hau CM; Rumley A; Lowe GD; Fowkes FG Blood Coagul Fibrinolysis; 2000 Jan; 11(1):43-50. PubMed ID: 10691098 [TBL] [Abstract][Full Text] [Related]
9. Plasma levels of von Willebrand factor and plasminogen activator in patients with arterial thromboembolism--with special reference to their correlation to the increased catabolism of both fibrinogen and platelets. Matsumoto M; Uchiyama T; Kobayashi N; Maekawa T Nihon Ketsueki Gakkai Zasshi; 1989 Sep; 52(6):1105-14. PubMed ID: 2588960 [TBL] [Abstract][Full Text] [Related]
10. von Willebrand factor, soluble P-selectin, tissue plasminogen activator and plasminogen activator inhibitor in atherosclerosis. Blann AD; Dobrotova M; Kubisz P; McCollum CN Thromb Haemost; 1995 Aug; 74(2):626-30. PubMed ID: 8584997 [TBL] [Abstract][Full Text] [Related]
11. Association between obesity and a prothrombotic state: the Framingham Offspring Study. Rosito GA; D'Agostino RB; Massaro J; Lipinska I; Mittleman MA; Sutherland P; Wilson PW; Levy D; Muller JE; Tofler GH Thromb Haemost; 2004 Apr; 91(4):683-9. PubMed ID: 15045128 [TBL] [Abstract][Full Text] [Related]
12. Determinants of haemostatic risk factors for coronary heart disease in obese children and adolescents. Gallistl S; Sudi KM; Borkenstein M; Troebinger M; Weinhandl G; Muntean W Int J Obes Relat Metab Disord; 2000 Nov; 24(11):1459-64. PubMed ID: 11126343 [TBL] [Abstract][Full Text] [Related]
13. Association of European population levels of thrombotic and inflammatory factors with risk of coronary heart disease: the MONICA Optional Haemostasis Study. Yarnell J; McCrum E; Rumley A; Patterson C; Salomaa V; Lowe G; Evans A Eur Heart J; 2005 Feb; 26(4):332-42; discussion 317-8. PubMed ID: 15618045 [TBL] [Abstract][Full Text] [Related]
14. Fibrin D-dimer, tissue-type plasminogen activator, von Willebrand factor, and risk of incident stroke in older men. Wannamethee SG; Whincup PH; Lennon L; Rumley A; Lowe GD Stroke; 2012 May; 43(5):1206-11. PubMed ID: 22382157 [TBL] [Abstract][Full Text] [Related]
15. The relation between insulin resistance and hemostasis: pleiotropic genes and common environment. de Lange M; Snieder H; Ariëns RA; Andrew T; Grant PJ; Spector TD Twin Res; 2003 Apr; 6(2):152-61. PubMed ID: 12724002 [TBL] [Abstract][Full Text] [Related]
16. 25-Hydroxyvitamin D and pre-clinical alterations in inflammatory and hemostatic markers: a cross sectional analysis in the 1958 British Birth Cohort. Hyppönen E; Berry D; Cortina-Borja M; Power C PLoS One; 2010 May; 5(5):e10801. PubMed ID: 20520739 [TBL] [Abstract][Full Text] [Related]
17. Relationship of tissue plasminogen activator, plasminogen activator inhibitor-1 and fibrinogen with coronary artery disease in South Indian male subjects. Deepa R; Velmurugan K; Saravanan G; Dwarakanath V; Agarwal S; Mohan V J Assoc Physicians India; 2002 Jul; 50():901-6. PubMed ID: 12126344 [TBL] [Abstract][Full Text] [Related]
18. Endothelial haemostatic factors may be associated with mortality in patients on long-term anticoagulant treatment. Brännström M; Jansson JH; Boman K; Nilsson TK Thromb Haemost; 1995 Aug; 74(2):612-5. PubMed ID: 8584993 [TBL] [Abstract][Full Text] [Related]
19. Increased levels of endothelial haemostatic markers in patients with coronary heart disease. Schumacher A; Seljeflot I; Sommervoll L; Christensen B; Otterstad JE; Arnesen H Thromb Res; 2002 Jan; 105(1):25-31. PubMed ID: 11864703 [TBL] [Abstract][Full Text] [Related]
20. Hemostatic state and atrial fibrillation (the Framingham Offspring Study). Feng D; D'Agostino RB; Silbershatz H; Lipinska I; Massaro J; Levy D; Benjamin EJ; Wolf PA; Tofler GH Am J Cardiol; 2001 Jan; 87(2):168-71. PubMed ID: 11152833 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]